Choriocarcinoma Syndrome as an Initial Presentation of Testicular Cancer

Choriocarcinoma syndrome (CS) is a rare clinical entity within the spectrum of nonseminomatous germ-cell tumors (NSGCT). It is characterized by the abrupt establishment of rapidly progressive and hemorrhagic tumors associated with very high levels of the beta fraction of human chorionic gonadotropin...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlos Eduardo Salazar-Mejía, María Elena García-Gutiérrez, María Inés Contreras-Salcido, Carlos Javier Rodríguez-Álvarez, Blanca Otilia Wimer-Castillo, Jackeline Grace Lara-Campos, Edio Llerena-Hernández, José Luis González-Vela, David Hernández-Barajas
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2018/8065615
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548528747970560
author Carlos Eduardo Salazar-Mejía
María Elena García-Gutiérrez
María Inés Contreras-Salcido
Carlos Javier Rodríguez-Álvarez
Blanca Otilia Wimer-Castillo
Jackeline Grace Lara-Campos
Edio Llerena-Hernández
José Luis González-Vela
David Hernández-Barajas
author_facet Carlos Eduardo Salazar-Mejía
María Elena García-Gutiérrez
María Inés Contreras-Salcido
Carlos Javier Rodríguez-Álvarez
Blanca Otilia Wimer-Castillo
Jackeline Grace Lara-Campos
Edio Llerena-Hernández
José Luis González-Vela
David Hernández-Barajas
author_sort Carlos Eduardo Salazar-Mejía
collection DOAJ
description Choriocarcinoma syndrome (CS) is a rare clinical entity within the spectrum of nonseminomatous germ-cell tumors (NSGCT). It is characterized by the abrupt establishment of rapidly progressive and hemorrhagic tumors associated with very high levels of the beta fraction of human chorionic gonadotropin (β-hCG) and with a very poor prognosis, particularly in patients with β-hCG values above 50,000 IU/L. We present the case of a 17-year-old man with a sudden onset nonmassive hemoptysis. Physical examination revealed a right testicular mass. Imaging studies showed metastatic lung, bone, and retroperitoneal disease. β-hCG serum levels were 222,493.21 IU/L, AFP 1.56 ng/mL, and DHL 457 IU/L. Histopathological study after right radical orchiectomy showed a mixed germ-cell tumor. Based on poor-risk characteristics, chemotherapy was started with an adequate clinical response. Physicians should be aware of the potential complications of CS in the treatment of testicular cancer with high β-hCG levels since they could be associated with a rapidly progressive and high-volume disease. Patients in this category should be referred to the centers experienced in the treatment of advanced germ-cell tumors. Due to the severity of the presentation, hemodynamic monitoring, ideally in an intensive care unit, is essential as well as timely administration of cytotoxic treatment.
format Article
id doaj-art-2d5c66963b704dd08763aed397377aa5
institution Kabale University
issn 2090-6706
2090-6714
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Oncological Medicine
spelling doaj-art-2d5c66963b704dd08763aed397377aa52025-02-03T06:13:50ZengWileyCase Reports in Oncological Medicine2090-67062090-67142018-01-01201810.1155/2018/80656158065615Choriocarcinoma Syndrome as an Initial Presentation of Testicular CancerCarlos Eduardo Salazar-Mejía0María Elena García-Gutiérrez1María Inés Contreras-Salcido2Carlos Javier Rodríguez-Álvarez3Blanca Otilia Wimer-Castillo4Jackeline Grace Lara-Campos5Edio Llerena-Hernández6José Luis González-Vela7David Hernández-Barajas8Centro Universitario Contra el Cáncer, University Hospital “Dr. José Eleuterio González” and Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, MexicoCentro Universitario Contra el Cáncer, University Hospital “Dr. José Eleuterio González” and Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, MexicoCentro Universitario Contra el Cáncer, University Hospital “Dr. José Eleuterio González” and Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, MexicoCentro Universitario Contra el Cáncer, University Hospital “Dr. José Eleuterio González” and Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, MexicoCentro Universitario Contra el Cáncer, University Hospital “Dr. José Eleuterio González” and Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, MexicoCentro Universitario Contra el Cáncer, University Hospital “Dr. José Eleuterio González” and Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, MexicoCentro Universitario Contra el Cáncer, University Hospital “Dr. José Eleuterio González” and Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, MexicoCentro Universitario Contra el Cáncer, University Hospital “Dr. José Eleuterio González” and Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, MexicoCentro Universitario Contra el Cáncer, University Hospital “Dr. José Eleuterio González” and Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, MexicoChoriocarcinoma syndrome (CS) is a rare clinical entity within the spectrum of nonseminomatous germ-cell tumors (NSGCT). It is characterized by the abrupt establishment of rapidly progressive and hemorrhagic tumors associated with very high levels of the beta fraction of human chorionic gonadotropin (β-hCG) and with a very poor prognosis, particularly in patients with β-hCG values above 50,000 IU/L. We present the case of a 17-year-old man with a sudden onset nonmassive hemoptysis. Physical examination revealed a right testicular mass. Imaging studies showed metastatic lung, bone, and retroperitoneal disease. β-hCG serum levels were 222,493.21 IU/L, AFP 1.56 ng/mL, and DHL 457 IU/L. Histopathological study after right radical orchiectomy showed a mixed germ-cell tumor. Based on poor-risk characteristics, chemotherapy was started with an adequate clinical response. Physicians should be aware of the potential complications of CS in the treatment of testicular cancer with high β-hCG levels since they could be associated with a rapidly progressive and high-volume disease. Patients in this category should be referred to the centers experienced in the treatment of advanced germ-cell tumors. Due to the severity of the presentation, hemodynamic monitoring, ideally in an intensive care unit, is essential as well as timely administration of cytotoxic treatment.http://dx.doi.org/10.1155/2018/8065615
spellingShingle Carlos Eduardo Salazar-Mejía
María Elena García-Gutiérrez
María Inés Contreras-Salcido
Carlos Javier Rodríguez-Álvarez
Blanca Otilia Wimer-Castillo
Jackeline Grace Lara-Campos
Edio Llerena-Hernández
José Luis González-Vela
David Hernández-Barajas
Choriocarcinoma Syndrome as an Initial Presentation of Testicular Cancer
Case Reports in Oncological Medicine
title Choriocarcinoma Syndrome as an Initial Presentation of Testicular Cancer
title_full Choriocarcinoma Syndrome as an Initial Presentation of Testicular Cancer
title_fullStr Choriocarcinoma Syndrome as an Initial Presentation of Testicular Cancer
title_full_unstemmed Choriocarcinoma Syndrome as an Initial Presentation of Testicular Cancer
title_short Choriocarcinoma Syndrome as an Initial Presentation of Testicular Cancer
title_sort choriocarcinoma syndrome as an initial presentation of testicular cancer
url http://dx.doi.org/10.1155/2018/8065615
work_keys_str_mv AT carloseduardosalazarmejia choriocarcinomasyndromeasaninitialpresentationoftesticularcancer
AT mariaelenagarciagutierrez choriocarcinomasyndromeasaninitialpresentationoftesticularcancer
AT mariainescontrerassalcido choriocarcinomasyndromeasaninitialpresentationoftesticularcancer
AT carlosjavierrodriguezalvarez choriocarcinomasyndromeasaninitialpresentationoftesticularcancer
AT blancaotiliawimercastillo choriocarcinomasyndromeasaninitialpresentationoftesticularcancer
AT jackelinegracelaracampos choriocarcinomasyndromeasaninitialpresentationoftesticularcancer
AT ediollerenahernandez choriocarcinomasyndromeasaninitialpresentationoftesticularcancer
AT joseluisgonzalezvela choriocarcinomasyndromeasaninitialpresentationoftesticularcancer
AT davidhernandezbarajas choriocarcinomasyndromeasaninitialpresentationoftesticularcancer